123 related articles for article (PubMed ID: 1849792)
1. Altered HLA class I expression in non-small cell lung cancer is independent of c-myc activation.
Redondo M; Ruiz-Cabello F; Concha A; Cabrera T; Pérez-Ayala M; Oliva MR; Garrido F
Cancer Res; 1991 May; 51(9):2463-8. PubMed ID: 1849792
[TBL] [Abstract][Full Text] [Related]
2. Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters.
Redondo M; Concha A; Oldiviela R; Cueto A; Gonzalez A; Garrido F; Ruiz-Cabello F
Cancer Res; 1991 Sep; 51(18):4948-54. PubMed ID: 1654207
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the expression of major histocompatibility complex class I genes in human colorectal cancer.
Soong TW; Hui KM
Cancer Detect Prev; 1991; 15(3):231-9. PubMed ID: 1905582
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines.
Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW
Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249
[TBL] [Abstract][Full Text] [Related]
5. [Immunologic modulation of tumor aggressiveness in cancer of the larynx. I. Genetic and molecular studies of HLA class I antigens].
Esteban F; Concha A; Ruiz-Cabello F; Garrido F
Acta Otorrinolaringol Esp; 1990; 41(5):297-303. PubMed ID: 2076309
[TBL] [Abstract][Full Text] [Related]
6. Loss of HLA haplotype in lung cancer cell lines: implications for immunosurveillance of altered HLA class I/II phenotypes in lung cancer.
Hiraki A; Kaneshige T; Kiura K; Ueoka H; Yamane H; Tanaka M; Harada M
Clin Cancer Res; 1999 Apr; 5(4):933-6. PubMed ID: 10213231
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis-independent retinoblastoma protein rescue of HLA class II messenger RNA IFN-gamma inducibility in non-small cell lung carcinoma cells. Lack of surface class II expression associated with a specific defect in HLA-DRA induction.
Lu Y; Boss JM; Hu SX; Xu HJ; Blanck G
J Immunol; 1996 Apr; 156(7):2495-502. PubMed ID: 8786310
[TBL] [Abstract][Full Text] [Related]
8. [Tissue array analysis of the aberrant expression of HLA class I molecules in human non small cell lung cancer].
Suzuki H; Higuchi M; Hasegawa T; Yonechi A; Ohsugi J; Yamada F; Hoshino M; Shio Y; Fujiu K; Gotoh M
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1713-6. PubMed ID: 17212084
[TBL] [Abstract][Full Text] [Related]
9. Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer.
Yazawa T; Kamma H; Fujiwara M; Matsui M; Horiguchi H; Satoh H; Fujimoto M; Yokoyama K; Ogata T
J Pathol; 1999 Jan; 187(2):191-9. PubMed ID: 10365094
[TBL] [Abstract][Full Text] [Related]
10. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification.
Shivapurkar N; Reddy J; Matta H; Sathyanarayana UG; Huang CX; Toyooka S; Minna JD; Chaudhary PM; Gazdar AF
Oncogene; 2002 Dec; 21(55):8510-4. PubMed ID: 12466971
[TBL] [Abstract][Full Text] [Related]
11. MHC class I expression in HPV 16 positive cervical carcinomas is post-transcriptionally controlled and independent from c-myc overexpression.
Cromme FV; Snijders PJ; van den Brule AJ; Kenemans P; Meijer CJ; Walboomers JM
Oncogene; 1993 Nov; 8(11):2969-75. PubMed ID: 8414499
[TBL] [Abstract][Full Text] [Related]
12. Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2.
Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Muramatsu M; Yamaguchi K; Fukuhara S
J Cancer Res Clin Oncol; 2002 Nov; 128(11):581-8. PubMed ID: 12458337
[TBL] [Abstract][Full Text] [Related]
13. Major histocompatibility complex class I and class II expression in renal cell carcinoma and modulation by interferon gamma.
Gastl G; Ebert T; Finstad CL; Sheinfeld J; Gomahr A; Aulitzky W; Bander NH
J Urol; 1996 Jan; 155(1):361-7. PubMed ID: 7490887
[TBL] [Abstract][Full Text] [Related]
14. In vitro modulation and relationship between N-myc and HLA class I RNA steady-state levels in human neuroblastoma cells.
Gross N; Beck D; Favre S
Cancer Res; 1990 Dec; 50(23):7532-6. PubMed ID: 1701347
[TBL] [Abstract][Full Text] [Related]
15. Limitation of differential expression of HLA-A,B,C antigens on choriocarcinoma cell lines by messenger RNA for HLA heavy chain but not by beta 2-microglobulin.
Kawata M; Sizer K; Sekiya S; Parnes JR; Herzenberg LA
Cancer Res; 1984 Sep; 44(9):4011-6. PubMed ID: 6204750
[TBL] [Abstract][Full Text] [Related]
16. Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics.
Takahashi T; Obata Y; Sekido Y; Hida T; Ueda R; Watanabe H; Ariyoshi Y; Sugiura T; Takahashi T
Cancer Res; 1989 May; 49(10):2683-8. PubMed ID: 2540905
[TBL] [Abstract][Full Text] [Related]
17. Lack of class I HLA expression in neuroblastoma is associated with high N-myc expression and hypomethylation due to loss of the MEMO-1 locus.
Cheng NC; Beitsma M; Chan A; Op den Camp I; Westerveld A; Pronk J; Versteeg R
Oncogene; 1996 Oct; 13(8):1737-44. PubMed ID: 8895520
[TBL] [Abstract][Full Text] [Related]
18. Activation of myc gene family in human lung carcinomas and during heterotransplantation into nude mice.
Gazzeri S; Brambilla E; Jacrot M; Chauvin C; Benabid AL; Brambilla C
Cancer Res; 1991 May; 51(10):2566-71. PubMed ID: 1850659
[TBL] [Abstract][Full Text] [Related]
19. c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer.
Robinson LA; Smith LJ; Fontaine MP; Kay HD; Mountjoy CP; Pirruccello SJ
Ann Thorac Surg; 1995 Dec; 60(6):1583-91. PubMed ID: 8787447
[TBL] [Abstract][Full Text] [Related]
20. Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas.
Cordon-Cardo C; Fuks Z; Drobnjak M; Moreno C; Eisenbach L; Feldman M
Cancer Res; 1991 Dec; 51(23 Pt 1):6372-80. PubMed ID: 1933900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]